Compare Lemonade Inc (LMND) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lemonade Inc vs Recursion Pharmaceuticals Inc — how do they compare? Lemonade Inc trades at $68.75 (market cap $5.18B), while Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B). The key difference: Lemonade Inc is far larger — about 3.4× Recursion Pharmaceuticals Inc's market cap, and Lemonade Inc is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| LMND | RXRX | |
|---|---|---|
Market Cap | $5.18B | $1.53B |
Sector | Financials | Health |
52-Week High | $96.57 | $6.79 |
52-Week Low | $36.28 | $2.84 |
Enterprise Value | $5.01B | $946.50M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lemonade (LMND) trades at $68.62, up 2.14% today, with a neutral technical signal and bullish moving averages. Revenue growth is strong, reaching $737.90 million in 2025, but the company remains unprofitable with a net income margin of -22.43%. Recent news highlights expansion into new states and a renegotiated reinsurance program, while analysts are divided with a consensus price target of $69.60.
The outlook hinges on Lemonade's path to profitability, with guidance for positive adjusted EBITDA by year-end. Opportunities include accelerating top-line growth and AI-driven efficiency, but risks persist from sustained losses, competitive pressures, and execution challenges. The stock's valuation at a P/S of 5.97 reflects growth expectations amid uncertainty.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lemonade Inc
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.
Read more on LMND →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
